Featured News
More News
What happens when a person with prediabetes get a viral infection? New study provides in-depth look
As the number of individuals with Type 2 diabetes in the United States continues to climb, researchers at Stanford Medicine are investigating the connection between a condition known as prediabetes -- an early indicator of diabetes that involves higher-than-normal blood sugar levels -- and immune and microbiome health.
SDRC funded study led by Dr. Joe Wu shows that e-cigarette flavorings have damaging effects
E-cigarette flavorings damage human blood vessel cells grown in the lab even in the absence of nicotine, Stanford researchers and their colleagues found. Cinnamon and menthol flavors were particularly harmful.
Study shows how big data can be used for personal health
Years-long tracking of individuals’ biology helped define what it meant for them to be healthy and showed how changes from the norm could signal disease, a Stanford-led study reports.
Trainees honored at the 4th Annual Frontiers in Diabetes Research Symposium on April 24th, 2019 with Best Poster Awards!
Keren Hilgendorf, Owen Jiang, and Yunshin Jung were awarded the Best Poster Awards at the Fourth Annual Frontiers in Diabetes Research Symposium.
Drug reduces risk of kidney failure in people with diabetes, study finds
Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.
New AI-powered algorithm offers a more accurate, accessible method for diagnosing diabetes subtypes and tailoring treatments, with potential for widespread impact.